touchPODCAST
Episodes
Experts discuss the latest data for emerging HER2-directed therapies in advanced breast cancer
10 Nov 2021
Contributed by Lukas
touchPANEL DISCUSSION for touchONCOLOGY Listen as leading experts discuss the latest clinical data for emerging HER2-directed therapies and review nov...
Making the case for the MDT in NSCLC
10 Nov 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to a medical oncologist, a pathologist, a radiation oncologist and an oncology nurse practitioner discuss how to opt...
The role of biomarker testing in NSCLC
10 Nov 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to a medical oncologist and a pathologist discuss the evolving role of biomarker testing in NSCLC in the light of em...
Navigating treatment decisions in NSCLC
10 Nov 2021
Contributed by Lukas
Listen to a medical oncologist, a pathologist and an oncology nurse practitioner discuss the evolving treatment landscape and how treatment decisions ...
Initial assessment of NSCLC
10 Nov 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to a medical oncologist and a radiation oncologist discuss the importance of the initial assessment in NSCLC and the...
Experts discuss the emerging role of SERDs in HR+ breast cancer
05 Nov 2021
Contributed by Lukas
touchPANEL DISCUSSION for touchONCOLOGY Listen to leading experts review the latest advances in HR+ breast cancer, focusing on the management of speci...
Novel targeted therapies for NSCLC: Exploring HER2 dysregulation
26 Oct 2021
Contributed by Lukas
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of experts discuss the latest clinical research in HER2 dysregulation and potential HER2-ta...
Experts discuss non-steroidal MRAs for the treatment of patients with T2D and CKD
25 Oct 2021
Contributed by Lukas
touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to leading experts discuss why the treatment landscape for patients with T2D and CKD requires nove...
Immunotherapy and evolving approaches for basal cell carcinoma
18 Oct 2021
Contributed by Lukas
touchPANEL DISCUSSION for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with EGFR-mutant NSCLC, and the rati...
MDT and patient perspectives on real-world use of antihyperglycemic therapies to manage T2D and obesity
13 Oct 2021
Contributed by Lukas
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient discuss real-world use of antihyperglycemic therapie...
MDT and patient perspectives on antihyperglycemic therapies and their association with weight loss
13 Oct 2021
Contributed by Lukas
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the importance of weight loss in T2D; GLP-1 ...
Perspectives on the mechanism linking obesity with T2D
13 Oct 2021
Contributed by Lukas
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the mechanism linking obesity with T2D and share their obs...
Frontline IO for advanced NSCLC: Updates from ASCO and ESMO 2021
06 Oct 2021
Contributed by Lukas
touchCONGRESS for touchRESPIRATORY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunothe...
Frontline IO for advanced NSCLC: Updates from ASCO and ESMO 2021
06 Oct 2021
Contributed by Lukas
touchCONGRESS for touchONCOLOGY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherap...
Type 2 diabetes experts discuss achieving individualized glycemic targets in patients with T2D
30 Sep 2021
Contributed by Lukas
touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Vincent Woo in conversation with Dr Joanna Van. They respond to questions submitted by the HC...
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 3
23 Sep 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determ...
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 2
23 Sep 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team review a patient profile and describe how they would determine suitabil...
Investigating immunotherapies for endometrial cancer: Working as a MDT to identify patients and improve outcomes - Part 1
23 Sep 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the latest data on PD-1/PD-L1 inhibitors and what they mean for...
Immunotherapy and evolving approaches for basal cell carcinoma
17 Sep 2021
Contributed by Lukas
touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma,...
Immunotherapy and evolving approaches for basal cell carcinoma
17 Sep 2021
Contributed by Lukas
touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, a...
What is the long-term picture for patients with EGFR-mutant NSCLC?
15 Sep 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to a medical oncologist and an oncology nurse practitioner discuss how to involve the patient in treatment decisions...
What are the implications of adjuvant therapy data on biomarker evaluation?
15 Sep 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NS...
How is the advent of adjuvant therapy in NSCLC changing our approach to surgery?
15 Sep 2021
Contributed by Lukas
touchMDT for touchONCOLOGY Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSC...
Patient education, evidence-based treatment and biomarkers in HFrEF
29 Jul 2021
Contributed by Lukas
touchPANEL DISCUSSION for touchCARDIO Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to impl...
Highlights from EHA2021 Virtual 2021: Focus on MDS and AML
20 Jul 2021
Contributed by Lukas
touchCONGRESS for touchONCOLOGY Listen to Prof. Uwe Platzbecker (Germany) cover key data presented at EHA2021 Virtual on new and emerging treatments f...
Perspectives on the latest data for novel lipid-lowering therapies
20 Jul 2021
Contributed by Lukas
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they...
Perspectives on how novel lipid-lowering therapies may help address current unmet needs
20 Jul 2021
Contributed by Lukas
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how...
Perspectives on the risk factors for ASCVD and guidelines for dyslipidaemia management
20 Jul 2021
Contributed by Lukas
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD an...
Perspectives on the latest data for novel lipid-lowering therapies
20 Jul 2021
Contributed by Lukas
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they...
Perspectives on how novel lipid-lowering therapies may help address current unmet needs
20 Jul 2021
Contributed by Lukas
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel ...
Perspectives on the risk factors for ASCVD and guidelines for dyslipidaemia management
20 Jul 2021
Contributed by Lukas
touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guide...
HR+/HER2- advanced breast cancer: How do the latest data on CDK4/6 inhibitors inform clinical decision-making?
30 Jun 2021
Contributed by Lukas
touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts in breast cancer share their opinion on the latest data which may help guide the use ...
Paving the way for optimal disease control in moderate-to-severe type 2 asthma
26 Apr 2021
Contributed by Lukas
touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma an...
Paving the way for optimal disease control in moderate-to-severe type 2 asthma
22 Apr 2021
Contributed by Lukas
touchPANEL DISCUSSION for touchRESPIRATORY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma a...
ACR 2020 – Predictors of Response in Nr‑axSpA Treated with Certolizumab Pegol: The C-axSpAnd Study
17 Mar 2021
Contributed by Lukas
touchCONGRESS for touchIMMUNOLOGY Walter Maksymowych (University of Alberta, Alberta, Canada) talks to touchIMMUNOLOGY about the results of the C-axS...
MAb biosimilars for solid tumours: Perspectives for pharmacists
09 Mar 2021
Contributed by Lukas
touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss how monoclonal antibody (MAb) biosimilars for solid tumours are developed and...
Highlights from SABCS 2020 Virtual
18 Jan 2021
Contributed by Lukas
touchCONGRESS for touchONCOLOGY Listen to key highlights from SABCS Virtual 2020. This touchPODCAST is presented by Prof. Dr Nadia Harbeck. We ...
Highlights from ESMO 2020 Virtual
14 Jan 2021
Contributed by Lukas
touchCONGRESS for touchONCOLOGY Listen to key highlights from ESMO Virtual 2020. This touchPODCAST is presented by Dr Catherine Kelly. We specifical...